Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say https://t.co/ccBuRh6bqu https://t.co/ccBuRh6bqu— Reuters (@Reuters) April 22, 2026
Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say
@Reuters·X: @Reuters··1 min read
X
Continue reading on X: @Reuters
This article was sourced from X: @Reuters's RSS feed. Visit the original for the complete story.